Exspanding the Knowledge About TNPO2-Associated Disorders

Recruiting Observational Study
TNPO2
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
50 (estimated)
Sponsor
Charite University, Berlin, Germany · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The Target-TNPO2 is an international, multicenter observational registry designed to collect comprehensive clinical, genetic, neurodevelopmental, and longitudinal data from individuals with pathogenic or likely pathogenic variants in the TNPO2 gene. This aids to improve the knowledge and clinical progression on TNPO2-associated disorders. The investigators further aim to provide new insides into…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * TNPO2 variant Exclusion Criteria: * no consent
Contacts

Lena-Luise Becker, Dr. med.

0049 30 450 566 112

lena-luise.becker@charite.de

CONTACT

Angela M. Kaindl, Prof. Dr.

0049 30 450 566112

angela.kaindl@charite.de

CONTACT